Boston Scientific announced that it has entered into a definitive agreement with Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, to sell its BTG Specialty Pharmaceuticals business for $800 million in cash.
02 Dec 2020
30 Nov 2020
Dr. Reddy’s to acquire select anti-allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan
Dr. Reddy’s Laboratories has entered into a definitive agreement with Glenmark Pharmaceuticals to acquire, subject to completion of certain precedent actions and closing activities, brands Momat Rino (for Russia, Kazakhstan and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan and Uzbekistan), Glenspray and Glenspray Active (for Ukraine), along-with rights to the trademarks, dossiers and patents for the territories mentioned.
26 Nov 2020
The European Commission (EC) has approved an agreement to purchase an initial 80 million doses of mRNA-1273, a vaccine candidate against Covid-19, from Moderna.
18 Nov 2020
Moderna, a new generation of transformative medicines for patients, today announced a supply agreement with the UK government to supply mRNA-1273, its Covid-19 vaccine candidate, beginning in March 2021 if it is approved for use by UK regulatory authorities.
02 Nov 2020
Cheplapharm Arzneimittel has agreed to acquire commercial rights of heart failure and hypertension drugs from AstraZeneca in a deal valued at around $400m.
29 Oct 2020
Eli Lilly has secured a $375m contract from the US government to supply 300,000 doses of its bamlanivimab (LY-CoV555) 700mg investigational neutralising antibody to fight against Covid-19.
28 Oct 2020
GlaxoSmithKline (GSK) and Sanofi have entered into a statement of intent with Gavi to supply 200 million doses of their adjuvanted recombinant protein-based Covid-19 vaccine to the COVAX Facility.
27 Oct 2020
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the Ministry of Public Health of Qatar for mRNA-1273, Moderna’s vaccine candidate against COVID-19, to support the Ministry’s ongoing efforts to secure early access to a safe and effective COVID-19 vaccine for the people of Qatar.
20 Oct 2020
Vifor Pharma has entered into a licence agreement with Cara Therapeutics to commercialise Korsuva (difelikefalin) to treat chronic kidney disease-associated pruritus (CKD-aP) in the US.
14 Oct 2020
The World Bank has sanctioned a package of $12bn for developing nations towards the purchase and distribution of Covid-19 vaccines, treatments, and tests.